ACADIA Pharmaceuticals

Total raised

$811,734,997

Investors

Funding rounds

• Post Ipo Equity

  $287.5MSep 16, 2019

• Post Ipo Equity

  $316.2MNov 29, 2018

• Post Ipo Equity

  $86.4MJan 1, 2013

• Grant

  National Institute of Neurological Disorders and Stroke (NINDS)

  $2.4MMay 16, 2011

• Post Ipo Equity

  Venrock, NEA - New Enterprise Associates

  $15MJan 10, 2011

• Post Ipo Equity

  Nomura Holdings, Oxford Bioscience Partners

  $20MFeb 6, 2006

• Post Ipo Equity

  Oxford Bioscience Partners

  $10MFeb 7, 2005

• Series F

  Oxford Bioscience Partners, OrbiMed Advisors, LD Pensions, Tekla Capital Management, ABN AMRO Fund, Federated Investors, Forbion Capital Partners

  $25MMar 30, 2003

• Debt Financing

  Tekla Life Sciences Investors, The Kaufman Fund, DKA Capital, Pacific Rim Ventures, OrbiMed Advisors

  $22MJun 19, 2000

• Series D

  LD Pensions, DKA Capital

  $10.7MAug 30, 1998

• Series B

  BankInvest, LD Pensions, DKA Capital

  $3MAug 12, 1997

• Series A

  BankInvest, LD Pensions, DKA Capital

  $6MFeb 3, 1997

• Debt Financing

  Vækstfonden

  $7.5MFeb 3, 1997

• IPO

  UndisclosedJan 1, 1985